Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor
- PMID: 19343764
- DOI: 10.1002/cmdc.200800443
Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor
Abstract
A computer-assisted method for the generation of pseudoreceptor models is presented together with two practical applications. From a three-dimensional alignment of known histamine H(4) receptor ligands, a pseudoreceptor model of the putative ligand binding site was constructed and used for virtual screening of a large collection of commercially available compounds. Two bioactive chemotypes were retrieved, demonstrating the general applicability of the approach. The pseudoreceptor model was also used to find the putative ligand binding pocket within the transmembrane receptor domain. For each frame of a molecular dynamics simulation of a homology-based H(4) receptor model, we automatically extracted potential ligand binding pockets and used their compatibility with the pseudoreceptor as a selection criterion. The best-matching pocket fits perfectly with existing mutation data and previously published hypotheses suggesting Glu182(5.46) as the preferred binding partner of a positively charged moiety of H(4) receptor ligands. This new pseudoreceptor approach has demonstrated its suitability for both structure-based prioritization of protein receptor models, and ligand-based virtual screening with the aim to perform scaffold hopping.
Similar articles
-
Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.J Med Chem. 2008 Jun 12;51(11):3145-53. doi: 10.1021/jm7014777. Epub 2008 May 7. J Med Chem. 2008. PMID: 18459760
-
Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.Nat Rev Drug Discov. 2008 Aug;7(8):667-77. doi: 10.1038/nrd2615. Epub 2008 Jul 18. Nat Rev Drug Discov. 2008. PMID: 18636071 Review.
-
Delineation of agonist binding to the human histamine H4 receptor using mutational analysis, homology modeling, and ab initio calculations.J Chem Inf Model. 2008 Jul;48(7):1455-63. doi: 10.1021/ci700474a. Epub 2008 Jun 14. J Chem Inf Model. 2008. PMID: 18553960
-
Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?Proteins. 2003 Jan 1;50(1):5-25. doi: 10.1002/prot.10237. Proteins. 2003. PMID: 12471595
-
Major advances in the development of histamine H4 receptor ligands.Drug Discov Today. 2009 Aug;14(15-16):745-53. doi: 10.1016/j.drudis.2009.05.007. Epub 2009 May 27. Drug Discov Today. 2009. PMID: 19477292 Review.
Cited by
-
In Silico Adoption of an Orphan Nuclear Receptor NR4A1.PLoS One. 2015 Aug 13;10(8):e0135246. doi: 10.1371/journal.pone.0135246. eCollection 2015. PLoS One. 2015. PMID: 26270486 Free PMC article.
-
Sequential application of ligand and structure based modeling approaches to index chemicals for their hH4R antagonism.PLoS One. 2014 Oct 16;9(10):e109340. doi: 10.1371/journal.pone.0109340. eCollection 2014. PLoS One. 2014. PMID: 25330207 Free PMC article.
-
DOGS: reaction-driven de novo design of bioactive compounds.PLoS Comput Biol. 2012;8(2):e1002380. doi: 10.1371/journal.pcbi.1002380. Epub 2012 Feb 16. PLoS Comput Biol. 2012. PMID: 22359493 Free PMC article.
-
Lead identification and optimization of diaminopyrimidines as histamine H4 receptor ligands.Inflamm Res. 2010 Mar;59 Suppl 2:S249-51. doi: 10.1007/s00011-009-0143-2. Inflamm Res. 2010. PMID: 20012148
-
Understanding functional residues of the cannabinoid CB1.Curr Top Med Chem. 2010;10(8):779-98. doi: 10.2174/156802610791164210. Curr Top Med Chem. 2010. PMID: 20370713 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources